Ambee Pharmaceuticals (DHA:AMBEEPHA) Interest Expense: BDT Mil (TTM As of . 20)


DHA:AMBEEPHA Ambee Pharmaceuticals Plc DHA:AMBEEPHA
18 GF Score
Price BDT760.70
View Full Analysis

What is Ambee Pharmaceuticals Interest Expense?

Ambee Pharmaceuticals DHA:AMBEEPHA -0.48% 18 Interest Expense is BDT Mil as of . 20. GuruFocus rates DHA:AMBEEPHA with a GF Score™ of 18/100.

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Ambee Pharmaceuticals's interest expense for the six months ended in . 20 was BDT 0.00 Mil. Ambee Pharmaceuticals does not have enough years/quarters to calculate its interest expense for the trailing twelve months (TTM) ended in . 20.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Ambee Pharmaceuticals's Operating Income for the six months ended in . 20 was BDT 0.00 Mil. Ambee Pharmaceuticals's Interest Expense for the six months ended in . 20 was BDT 0.00 Mil. Ambee Pharmaceuticals did not have earnings to cover the interest expense. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Ambee Pharmaceuticals  (DHA:AMBEEPHA) Interest Expense Explanation

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense. The higher, the better.

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Ambee Pharmaceuticals's Interest Expense for the six months ended in . 20 was BDT0.00 Mil. Its Operating Income for the six months ended in . 20 was BDT0.00 Mil. And its Long-Term Debt & Capital Lease Obligation for the six months ended in . 20 was BDT0.00 Mil.

Ambee Pharmaceuticals's Interest Coverage for the quarter that ended in . 20 is calculated as

Ambee Pharmaceuticals had no long-term debt (1).

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The higher the ratio, the stronger the company's financial strength is.

Ambee Pharmaceuticals Interest Expense Historical Data

* Premium members only.

The historical data trend for Ambee Pharmaceuticals's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Ambee Pharmaceuticals Interest Expense Chart

Ambee Pharmaceuticals Annual Data
Trend
Interest Expense

Ambee Pharmaceuticals Semi-Annual Data
Interest Expense
DHA:AMBEEPHA
18GF Score
Ambee Pharmaceuticals Plc DHA:AMBEEPHA
Interest Expense is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Ambee Pharmaceuticals Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Frequently Asked Questions Learn more about Interest Expense →
What does a Interest Expense of BDT Mil mean?
Ambee Pharmaceuticals (DHA:AMBEEPHA) has a Interest Expense of BDT Mil as of . 20. Interest Expense is the amount a company pays on its long-term debt. View historical data on Ambee Pharmaceuticals and its competitors.
Is Ambee Pharmaceuticals' Interest Expense too high?
Ambee Pharmaceuticals' current Interest Expense is BDT Mil. Overall, Ambee Pharmaceuticals has a GF Score™ of 18/100, reflecting its overall financial health beyond just this single metric.
How does Ambee Pharmaceuticals' Interest Expense compare to IMNPQ?
Ambee Pharmaceuticals' Interest Expense of BDT Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Interest Expense for a Drug Manufacturers company?
A good Interest Expense depends on the Drug Manufacturers industry context. However, Interest Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Interest Expense mean?
A high Interest Expense can signal that a stock is expensive relative to its fundamentals. Interest Expense is the amount a company pays on its long-term debt. View historical data on Ambee Pharmaceuticals and its competitors. Ambee Pharmaceuticals's current Interest Expense is BDT Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ambee Pharmaceuticals stock overvalued right now?
Ambee Pharmaceuticals (DHA:AMBEEPHA) has a current Interest Expense of BDT Mil. The current Interest Expense is BDT Mil. Ambee Pharmaceuticals' overall GF Score™ is 18/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Interest Expense calculated?
Interest Expense is calculated from a company's financial statements. For Ambee Pharmaceuticals (DHA:AMBEEPHA), the current Interest Expense is BDT Mil as of . 20. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Ambee Pharmaceuticals Business Description

Address 184/1 Tejgaon Industrial Area, Dhaka, BGD, 1208
Ambee Pharmaceuticals Plc formerly Ambee Pharmaceuticals Ltd manufactures a wide range of pharmaceutical products in Bangladesh. It is engaged in the business of manufacturing drugs and medicine and sales. Its products are sold in the form of tablets, capsules, liquids, gels, and injectables.
18GF Score

Get the complete analysis for DHA:AMBEEPHA

Interest Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

BDT760.70
Price